LFST
LifeStance Health Group, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
12.47
▼ 0.18 (1.42%)
MARKET · —
Price
Open
12.80
Prev close
12.65
Day high
12.72
Day low
12.42
Volume
2.31M
Market cap
$4.76B
P/E (TTM)
95.92
52W range
4.77 – 12.97
Trailing performance
Returnvs SPY
1W
+0.40%
+1.8%
1M
+15.36%
+11.6%
3M
+67.16%
+64.1%
6M
+74.41%
+63.3%
YTD
+77.13%
+64.8%
1Y
+133.08%
+113.1%
3Y
+62.79%
-11.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$4.76B
Enterprise value$5.01B
Revenue (TTM)$1.58B
Gross profit$531.85M
EBITDA$135.00M
Net income$50.60M
EPS (TTM)$0.13
Free cash flow$172.36M
Total cash$225.94M
Total debt$474.15M
Book value / share$3.87
Shares outstanding382.06M
Float249.23M
Short % of float5.19%
Dividend yield—
Beta (5Y)1.20
Valuation & profitability ratios
Trailing P/E95.92
Forward P/E23.50
PEG ratio—
Price / sales—
Price / book3.22
EV / revenue3.16
EV / EBITDA37.13
Gross margin33.56%
Operating margin7.25%
Profit margin3.19%
Return on equity3.43%
Return on assets2.32%
Debt / equity32.10
Current ratio1.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $1.42B | $1.25B | $1.06B | $859.54M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $9.66M | -$57.44M | -$186.26M | -$215.56M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $9.66M | -$57.44M | -$186.26M | -$215.56M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.08 | 0.11 | +32.4% |
| Mar 2026 | 0.06 | 0.07 | +10.4% |
| Dec 2025 | 0.05 | 0.09 | +64.3% |
| Sep 2025 | 0.04 | 0.01 | -63.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.10 | 5 | $431.36M | +18.6% |
| Next quarter | 0.10 | 5 | $438.10M | +14.6% |
| Current year | 0.40 | 5 | $1.71B | +19.9% |
| Next year | 0.53 | 5 | $1.95B | +14.4% |
Analyst targets & ownership
Mean target$13.80
High target$18.00
Low target$12.00
Implied upside10.67%
Analyst count10
ConsensusBUY
Strong buy / Buy2 / 7
Hold2
Sell / Strong sell0 / 0
Held by insiders3.19%
Held by institutions95.63%
Institutions holding394
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
-51.75M
Net selling
Buy transactions
21
2.87M shares
Sell transactions
15
54.62M shares
Net transactions
+36
Buys less sells
Sell : buy shares
19.0 : 1
Heavily one-sided
Insider-held shares
12.20M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | DELUCA TERESA Director |
SELL | 7.50K | $95.10K | Direct |
| Aug 13, 26 | DELUCA TERESA Director |
SELL | 20.44K | $249.99K | Direct |
| Aug 11, 26 | BURDICK KENNETH A Director |
SELL | 500.00K | $5.75M | Direct |
| Aug 10, 26 | TPG GP A, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
SELL | 13.64M | $144.89M | Indirect |
| Aug 10, 26 | PAUNOVICH VUKASIN Chief Technology Officer |
SELL | 44.39K | $481.68K | Direct |
| Aug 10, 26 | MILLER LISA K Chief Operating Officer |
SELL | 47.91K | $519.85K | Direct |
| Jul 6, 26 | BURDICK KENNETH A Director |
STOCK | 45.49K | $0 | Direct |
| Jul 2, 26 | PERSONETTE SARAH Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | DELUCA TERESA Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | PALMER ERIC P. Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | BESSLER ROBERT Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | GOLTERMANN LORI Director |
STOCK | 35.49K | $0 | Direct |
| Jul 2, 26 | JUSTICE THURMAN Director |
STOCK | 35.49K | $0 | Direct |
| Jun 26, 26 | BESSLER ROBERT Director |
SELL | 894.34K | $9.06M | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BESSLER ROBERT |
Director | 1.31M | Stock Award(Grant) |
BLACK DARREN M |
Director | — | Sale |
BOURDON DAVID |
Chief Executive Officer | 1.40M | Stock Award(Grant) |
BURDICK KENNETH A |
Director | 3.02M | Sale |
PANTALEONI PABLO |
Officer | — | Sale |
PARDO RYAN |
Officer and Director | 3.65M | Stock Award(Grant) |
SHUEY ERIC A |
Director | — | Sale |
SILVERSMITH PARTNERS I GP, LLC |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
SUMMIT PARTNERS, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
TPG GP A, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
Moving averages & technicals
SMA 10
12.31
+1.28% from price
SMA 20
11.50
+8.43% from price
SMA 50
10.78
+15.67% from price
SMA 100
9.03
+38.07% from price
SMA 200
7.91
+57.58% from price
EMA 12
12.11
+2.99% from price
EMA 26
11.53
+8.11% from price
EMA 50
10.75
+16.01% from price
RSI (14)
63.8
Neutral
MACD (12,26,9)
0.57
Hist 0.09
ATR (14)
0.58
4.67% of price
Realised vol 30D
45.6%
Annualised
Bollinger upper
13.25
20, 2σ
Bollinger lower
9.75
20, 2σ
50 / 200 cross
Golden
10.78 vs 7.91
Trend bias
Above 200
+57.58%
Risk profile
Beta vs SPY
0.66
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
45.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-17.1%
Peak to trough
Max drawdown 5Y
-76.7%
Peak to trough
ATR 14
0.58
4.67% of price
Beta (reported)
1.20
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.16
Call-heavy session
Put / call open interest
0.03
Positioning, not flow
Max pain
10.00
-19.8% from spot
ATM implied vol
62.5%
Nearest strike to spot
Skew (10% OTM)
-12.9%
Calls bid over puts
Call volume
93
Contracts, this expiry
Put volume
15
Contracts, this expiry
Heaviest call OI
15.00
901 contracts
Heaviest put OI
9.00
20 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
5 Insightful Analyst Questions From LifeStance Health Group’s Q2 Earnings Call
StockStory · 7d ago
Lifestance Health Group Insider Sold Shares Worth $5,755,000, According to a Recent SEC Filing
MT Newswires · 9d ago
LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know
Zacks · 9d ago
Zacks.com featured highlights include LifeStance Health, Tutor Perini, Valero Energy, SharkNinja and Lumentum
Zacks · 9d ago
Lifestance Health Group Insider Sold Shares Worth $481,675, According to a Recent SEC Filing
MT Newswires · 10d ago
LifeStance Health Group (LFST) Is Up 12.1% After Profit Turn, Higher Guidance And New Buyback Program
Simply Wall St. · 10d ago
5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence
Zacks · 10d ago
LifeStance Health (LFST) Upgraded to Buy: Here's Why
Zacks · 11d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.